Claire Auditeau: Thrilled to Share a Major Milestone From My PhD Journey!
Claire Auditeau, Medical Biologist – University Hospital Assistant at Greater Paris University Hospitals, shared on LinkedIn:
”Thrilled to share a major milestone from my PhD journey!
Our paper “Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease” has just been published in the American Journal of Hematology.
Our research has revealed that protein S significantly enhances the phagocytosis of phosphatidylserine-exposing erythrocytes and eryghosts.
This discovery is particularly significant for SCD patients, as we demonstrated that the accumulation of pro-coagulant and adherent eryghosts in circulation likely contributes to the pathogenesis of the disease.
These insights not only deepen our understanding of red blood cell clearance but also pave the way for exciting future therapeutic applications.
This four-year journey, at the crossroads of hemostasis and red blood cell biology, was made possible through a wonderful collaboration between HITh and BioTIGR.
Aurélie Fricot-Monsinjon, Camille Roussel, HITh lab, Inserm, Delphine Borgel, François Saller
Huge thanks to all co-authors and collaborators for their incredible teamwork and support throughout this project!
The article is available in open access.”
Read the full article here.
Article: Protein S Enhances the Phagocytosis of Phosphatidylserine-Exposing Erythrocytes: Implications in Sickle Cell Disease
Authors: Claire Auditeau, Aurélie Fricot, Raphaël Gauthier, Abdoulaye Sissoko, Zeynep Cacan, Céline Gounou, Laure Joseph, Sandra Manceau, Slimane Allali, Michael Dussiot, Mickael Marin, Alexis Lavergne, Mariem Khamari, Sophie Moog, Elsa Bianchini, Laetitia Claer, Sandrine Laurance, Valentine Brousse, Sébastien Eymieux, Philippe Roingeard, Pascal Amireault, Thiago Trovati Maciel, Alain Brisson, Pierre Buffet, François Saller, Delphine Borgel, Camille Roussel
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 11, 2026, 17:00A Major Step Forward for the Global Bleeding Disorders Community – Haemophilia Foundation Australia
-
Feb 11, 2026, 16:47Pall T. Onundarson and Mandeep Mehra on Diverse Approaches to Anticoagulation in LVAD Patients
-
Feb 11, 2026, 16:37Rahul Gosain: Are Cancer Outcomes Directly Related to Lymphocyte Counts?
-
Feb 11, 2026, 16:35Are DOACs Actually Safer in Advanced Cirrhosis – RPTH Journal
-
Feb 11, 2026, 16:33Reza Shojaei: Transforming Canada’s Plasma System for Greater Resilience and Self-Sufficiency
-
Feb 11, 2026, 16:31Pat Garcia-Gonzalez: A Bold Plan to Double Impact and Reach 100,000 Patients by 2031
-
Feb 11, 2026, 16:20Ney Carter Borges։ Clinical Importance of Coronary Microcirculation in MINOCA and INOCA
-
Feb 11, 2026, 16:18The Hidden Risks of Blood Thinners and the Need for Safer Anticoagulants – National Blood Clot Alliance
-
Feb 11, 2026, 16:13Thomas Reiser: A Great Opportunity to Advance the Field of Thrombosis and Hemostasis